Group B Streptococcus MarketA typical bacterium that is frequently seen in the intestines or lower genital tract is group B strep (streptococcus). In healthy individuals, the bacterium is mostly harmless; but, in neonates, it can result in the deadly sickness known as GBS. <a href="https://www.delveinsight.com/report-store/group-b-streptococcus-gbs-epidemiology-forecast" rel="noopener noreferrer" target="_blank" style="background-color: transparent; color: rgb(17, 85, 204);">Group B Streptococcus Epidemiology</a> Insights (2022)<ul><li>The Total Group B Streptococcus incident cases in the 7MM - ~227K cases in 2022</li><li>EU4 and the UK contributed ~20% of incident cases</li><li>Nearly 2 million pregnant women were estimated to have Group B Streptococcus colonization</li><li>Invasive type account for 22% of incident cases</li></ul> Group B Streptococcus Epidemiology Segmentation in the 7MM from 2019 to 2040<ul><li>Total Incident Cases</li><li>Type-specific Incident Cases</li><li>Age-specific Incident Cases of GBS by types</li><li>Number of Cases of GBS Colonization</li></ul> <a href="https://www.delveinsight.com/report-store/group-b-streptococcus-gbs-market" rel="noopener noreferrer" target="_blank" style="background-color: transparent; color: rgb(17, 85, 204);">Group B Streptococcus Market</a> Insight (2022)<ul><li>The Group B Streptococcus Market size in the 7MM was valued ~USD 194 million in 2022</li><li>The United States captured the largest market size for Group B Streptococcus among the 7MM regions</li></ul> Group B Streptococcus Emerging Drugs and Key Companies<ul><li>GBS-NN/NN2: Minervax ApS</li><li>GBS 6 (PF-06760805): Pfizer, and others</li></ul>

Group B Streptococcus Market Infographics

Group B Streptococcus Symptoms, Treatment, epidemiology, companies, drugs, infographic is a short guide to understand the problem and market landscape